Cells | Free Full-Text | Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
Estrogen signaling and regulation of Notch. The ERα ligand... | Download Scientific Diagram
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Dual-mechanism estrogen receptor inhibitors | PNAS
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text
Frontiers | Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer
EREs).
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling - ScienceDirect
エストロゲン/プロゲストゲン受容体阻害 | Androgen Receptor Inhibition
IJMS | Free Full-Text | Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
Dual-mechanism estrogen receptor inhibitors | PNAS
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Frontiers | G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer | Oncotarget
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
